Home » DUSA PHARMACEUTICALS AND PHOTOCURE ASA SETTLE PATENT DISPUTES
DUSA PHARMACEUTICALS AND PHOTOCURE ASA SETTLE PATENT DISPUTES
Dusa Pharmaceuticals and PhotoCure ASA today announced a licensing agreement under which Dusa grants PhotoCure a worldwide license under its patents relating to ALA esters. PhotoCure will pay royalties on sales of its Metvix and Hexvix ester products as well as new products as long as Dusa holds patents in the US and certain other territories, including a prepaid royalty amount payable on 1 June 2006.
Market Wire (http://www.marketwire.com/mw/release_html_b1?release_id=132226)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May